Diabetic Macular Edema Market offers huge growth opportunities for the future
Industry Trend Analysis: The Global Diabetic Macular Edema Market is expected to be around $4 billion by 2025. Some of the key factors driving this market are high prevalence of diabetic retinopathy and diabetic macular edema and increasing prevalence of geriatric population around the world. According to the National Center for biotechnology Information, DME is expected to affect around 592 million people by 2035. With such high incidence of DME, the demand for therapies to treat DME is expected to considerably increase during the forecast period. Older adults are more susceptible to diabetes. With increasing prevalence of older population globally, the risk of DME is also expected to increase during the forecast period. For more information, click on the below link @ https://www.crystalmarketresearch.com/report/diabetic-macular-edema-market . Major Participants: Some of the key players operating in this market are, Bayer AG, F. Hoffmann-La Ro...